Cancer researchers highlight role of nanomedicine in next-generation immunotherapies

Scientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy with back-to-back review articles published in Nature Cancer and Trends in Cancer that look at how nanotechnology could reprogram the immune system and help overcome tumors’ defenses.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup